MAP3K5 and metabolic dysfunction-associated steatohepatitis: By regulating lipid and glucose metabolism, the ASK1 signaling pathway, which is aberrantly active in patients with obesity and NASH, may drive the progression of non-alcoholic fatty liver (NAFL) to NASH (41).